Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline

MLA

Yuqian Zhu, et al. “Ginsenoside Rg1 as a Promising Adjuvant Agent for Enhancing the Anti-Cancer Functions of Granulocytes Inhibited by Noradrenaline.” Frontiers in Immunology, vol. 14, Feb. 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1070679.

APA

Yuqian Zhu, Jingyao Chen, Jun Li, Chenqi Zhou, Xin Huang, & Bingdi Chen. (2023). Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1070679

Chicago

Yuqian Zhu, Jingyao Chen, Jun Li, Chenqi Zhou, Xin Huang, and Bingdi Chen. 2023. “Ginsenoside Rg1 as a Promising Adjuvant Agent for Enhancing the Anti-Cancer Functions of Granulocytes Inhibited by Noradrenaline.” Frontiers in Immunology 14 (February). doi:10.3389/fimmu.2023.1070679.